Laura G. Eichorn - Aug 16, 2022 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Role: Chief Financial Officer
Signature: /s/ Hugh Rienhoff, as Attorney-in-fact for Laura Eichorn
Stock symbol: IMGO
Transactions as of: Aug 16, 2022
Transactions value $: -$15,384
Form type: 4
Date filed: 8/18/2022, 05:50 PM
Previous filing: Jul 21, 2022
Next filing: Aug 24, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMGO	Common Stock	Options Exercise	$1.34K	+533	+0.26%	$2.52^*	208K	Aug 16, 2022	Direct	F1
transaction	IMGO	Common Stock	Sale	-$10.4K	-533	-0.26%	$19.50	208K	Aug 16, 2022	Direct	F1
transaction	IMGO	Common Stock	Options Exercise	$940	+373	+0.18%	$2.52^*	208K	Aug 17, 2022	Direct	F1
transaction	IMGO	Common Stock	Sale	-$7.27K	-373	-0.18%	$19.50	208K	Aug 17, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMGO	Stock Option (Right to Buy)	Options Exercise	$0	-533	-0.53%	$0.00	100K	Aug 16, 2022	Common Stock	533	$2.52	Direct	F1
transaction	IMGO	Stock Option (Right to Buy)	Options Exercise	$0	-373	-0.37%	$0.00	100K	Aug 17, 2022	Common Stock	373	$2.52	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2	The transaction was executed in multiple trades in prices ranging from $19.50 to $19.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Content

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

The transaction was executed in multiple trades in prices ranging from $19.50 to $19.51, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Remarks:

Chief Financial Officer